BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach.

导出 LinkOut

翻译打印收藏纠错

作者： Jenna M,Menger ^[1] ; Ryan S,Sathianathen ^[2] ; Kathleen M,Sakamoto ^[3] ; Nobuko,Hijiya ^[4]

作者单位： Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, 10069, USA. pnu9001@nyp.org. ^[1] Department of Pediatrics, Stanford University, Stanford, CA, 94305, USA. ^[2] Division of Hematology/Oncology, Department of Pediatrics, Stanford University, Stanford, CA, 94305, USA. ^[3] Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, 10069, USA. ^[4]

关键词 BCR-ABL1 CML Chronic myeloid leukemia Pediatric cancer TKI Tyrosine kinase inhibitor

主题词人类(Humans);儿童(Child);融合蛋白质类, bcr-abl(Fusion Proteins, bcr-abl);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);白血病, 髓样(Leukemia, Myeloid);蛋白激酶抑制剂(Protein Kinase Inhibitors)

DOI 10.1007/s11912-024-01502-z

PMID 38340217

发布时间 2024-05-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交